Chronic Anterior Knee Pain and Intra-Articular Inflammation That Remain After Recurrent Patellar Dislocation (Habitual Patellar Dislocation) — Dr. Moriwaki Draws the Line Between What Stem Cell Conditioned Media Knee Injection Can Address (the Intra-Articular Inflammatory Environment) and What It Cannot (Bony/Ligamentous Structural Instability)2026.08.06
Recurrent patellar dislocation (habitual patellar dislocation) is a condition — seen mainly in adolescent and young adult women — in which the kneecap (patella) repeatedly slips laterally out of its groove during everyday movements. Even in patients who are being managed conservatively after a first dislocation, and in patients who have undergone surgical reconstruction of the medial patellofemoral ligament (MPFL), it is not uncommon for chronic anterior knee pain to persist for months to years afterward: “my front knee always aches,” “my knee catches when I go down stairs,” “when I stand up after sitting for a long time there is a sharp pain around the kneecap.” The true nature of this persistent pain is often not simply “cured because the kneecap is no longer dislocating.” Rather, it lies in the cartilage damage that has progressed on the medial side of the patellofemoral joint with every dislocation and subluxation, together with the chronic synovitis inflammatory cycle that sustains it. In this article, Dr. Moriwaki of AVAN TOKYO Ginza honestly organizes what a stem cell conditioned media knee injection — a conservative option — can address and what it cannot in patients with chronic anterior knee pain and intra-articular inflammation remaining after recurrent patellar dislocation.
Key Points of This Article
– Recurrent patellar dislocation is common in adolescent and young adult women; instability of the patellofemoral joint becomes chronic after the first dislocation, and anterior knee pain tends to persist even after dislocations stop
– Repeated dislocations and subluxations produce cartilage lesions on the medial patellar facet and on the femoral trochlea, along with synovial irritation and loose bodies; the intra-articular chronic inflammatory cycle becomes the substance of the chronic pain
– For the anterior knee pain that remains after recurrent patellar dislocation, a stem cell conditioned media knee injection is positioned as a conservative option that aims to modulate the intra-articular inflammatory environment
– A stem cell conditioned media knee injection does not correct the bony/anatomical instability itself — such as trochlear dysplasia, patella alta, or an increased TT-TG distance
– Treatment design should run in parallel with bracing, exercise therapy centered on the vastus medialis obliquus (VMO), and, when needed, orthopedic surgery such as MPFL reconstruction
What Recurrent Patellar Dislocation Is — The Medical Background of “Once It Slips, It Slips Again”
The patella normally slides up and down along a rail called the trochlear groove at the distal end of the femur. When the knee is extended the patella sits above the groove; as the knee flexes, it settles more deeply into the trochlear groove. This motion is stabilized medially by the medial patellofemoral ligament (MPFL), laterally by the lateral retinaculum, and actively by the vastus medialis obliquus (VMO).
Most First-Time Dislocations Occur Laterally
A first patellar dislocation typically happens when the quadriceps contracts suddenly in a slightly flexed and externally rotated position of the lower leg — such as during a jump landing, a change of direction, or dance and cheer routines — allowing the patella to slip out laterally. At that moment the MPFL, which had been holding the patella from the medial side, is stretched or torn.
Anatomical Risk Factors Predispose to Re-Dislocation
Among patients with a first dislocation, a proportion have anatomical factors that make re-dislocation more likely. Representative examples include a shallow trochlear groove (trochlear dysplasia), a patella positioned higher than usual (patella alta), a laterally located tibial tubercle (increased TT-TG distance), and generalized joint laxity. In patients with several of these factors coexisting, even after choosing conservative treatment following the first dislocation, everyday activities or light sports can shift them into a condition in which dislocations and subluxations recur repeatedly.
Why Anterior Knee Pain Becomes Chronic After Repeated Dislocations
“The kneecap isn’t dislocating anymore, yet the front of my knee still hurts constantly.” This is a common complaint at follow-up visits. Behind it are changes that have been progressing quietly inside the joint with each dislocation.
Cartilage Damage on the Medial Patella and the Lateral Edge of the Femoral Trochlea
When the patella dislocates laterally and spontaneously reduces, or subluxes and returns, the medial facet of the patella and the lateral edge of the femoral trochlea rub against each other strongly. The resulting impaction and shear forces produce cartilage lesions — fissures, delamination, and defects (osteochondral lesion) — on the medial facet of the patella and the lateral trochlea. On arthroscopy it is not uncommon to see cartilage flaps floating up or small cartilage fragments circulating in the joint as loose bodies.
Chronic Synovitis as an “Inflammatory Cycle”
Cartilage debris and loose bodies continue to release degradation products and inflammatory cytokines into the joint fluid. The synovium reacts to this with chronic inflammation, over-produces joint fluid, and creates swelling, discomfort, and stiffness in the knee. From that synovium, further inflammatory cytokines are released and the surrounding cartilage metabolism worsens — this self-amplifying “intra-articular inflammatory cycle” is the substance of the chronic anterior knee pain that remains even after dislocations have stopped. In the long run it is also part of the background that can progress into patellofemoral osteoarthritis (PFOA).
What a Stem Cell Conditioned Media Knee Injection Can Address After Recurrent Patellar Dislocation
As described above, the core of the chronic pain that remains after repeated dislocations lies in the “intra-articular inflammatory cycle.” A stem cell conditioned media knee injection is a treatment that aims to act on this inflammatory environment itself.
The Concept of Modulating the Intra-Articular Inflammatory Environment
Stem cell conditioned media contains diverse bioactive substances secreted by cultured mesenchymal stem cells — growth factors such as TGF-β, IGF-1, FGF, HGF, and VEGF, anti-inflammatory cytokines, and exosomes. When injected into the knee joint cavity, basic research suggests these components can modulate the pro-inflammatory cytokine-dominant environment of chronic synovitis and act on the homeostatic maintenance of cartilage and synovial cells. That said, individual variability in humans is large, and the accumulation of comparative trials is still limited.
A Conservative Approach to Pain and Joint Swelling
Clinically, for chronic anterior knee pain and recurrent joint effusion remaining in a knee after repeated dislocations, a stem cell conditioned media knee injection is considered as an option less likely to accumulate cartilage burden than repeated steroid injections. Common approaches for knee joint injection include the superolateral and infrapatellar routes; when necessary, ultrasound guidance is used to confirm access to the patellofemoral joint space. Please also see our page on stem cell conditioned media joint injection for the overall picture of this treatment.
What a Stem Cell Conditioned Media Knee Injection Cannot Address — Drawing the Line with Structural Problems
On the other hand, what makes dislocations recur is essentially “the very structure that allows the patella to slip laterally.” This is beyond the reach of a stem cell conditioned media knee injection.
Bony and Anatomical Factors Are Not Changed by Injection
Bony and alignment-related instability — a shallow trochlear groove (trochlear dysplasia), patella alta, an increased TT-TG distance, an increased Q-angle, or increased femoral anteversion — is not corrected by injecting stem cell conditioned media. In patients with strong such factors in whom dislocations and subluxations continue to recur, priority should first be given to stabilization through bracing and exercise therapy, and then to discussing with an orthopedic specialist the indication for surgery such as MPFL reconstruction, trochleoplasty, or tibial tubercle transfer. For general information on joint disease, please also refer to the site of the Japanese Orthopaedic Association.
“Pain Relief” Does Not Equal “Dislocation Risk Removed”
Even if a stem cell conditioned media knee injection calms inflammation and pain, that does not mean the instability of the patellofemoral joint itself has been fixed. On the contrary, rushing back to sports because the pain has eased and then triggering a re-dislocation can add new cartilage damage on top of what already exists. In treatment discussions it is important that patient and physician share this line in the same words.
Treatment Design — Building It in Parallel with Bracing, Rehabilitation, and Surgery
When incorporating a stem cell conditioned media knee injection into the care of a patient with recurrent patellar dislocation, it is essential not to treat it as a standalone therapy. Combined with taping and patellar braces that compensate for reduced medial patellar support, exercise therapy strengthening the quadriceps (particularly the VMO) and the hip external rotators, insoles adjusted to lower-limb alignment, and — when needed — MPFL reconstruction or bony procedures, the calm intra-articular environment gained from the conditioned media knee injection is more likely to last through daily activities and return to activity. Effect judgment is done over a scale of weeks to months, using pain scores, joint swelling, and sensations during stair use or knee flex/extend as key axes; the design also includes a decision to switch to orthopedic re-evaluation if the response is poor.
Frequently Asked Questions
Q. I have already undergone MPFL reconstruction — can I still receive a stem cell conditioned media knee injection?
Yes. In cases where an intra-articular inflammatory cycle remains after surgery and chronic anterior knee pain or joint effusion persists, a stem cell conditioned media knee injection can become an option. However, the timing needs to be adjusted based on your postoperative course, wound status, suture removal, and rehabilitation stage, so we decide only after sharing information between the orthopedic surgeon who performed your operation and our physicians.
Q. Can stem cell conditioned media knee injection be used for teenagers with recurrent patellar dislocation?
The growing knee requires considerations different from adults, such as growth plates that have not yet fused; and when strong bony factors underlie the condition, stabilization with bracing, exercise therapy, and — when needed — surgery is prioritized first. Before applying a stem cell conditioned media joint injection, we recommend first obtaining an accurate diagnosis and alignment assessment at a pediatric orthopedic clinic.
Q. Will a stem cell conditioned media knee injection cure patellar dislocation itself?
No. What makes dislocations recur is essentially the structural instability of the patellofemoral joint, and a stem cell conditioned media knee injection does not reconstruct bony morphology or the ligament itself. Please understand that it is a conservative option aimed at modulating the intra-articular inflammatory environment; dislocation prevention itself is the role of bracing, exercise therapy, and in some cases surgery.
Q. How long does it take to judge the effect?
Generally we follow the course from several weeks to several months after injection and evaluate on axes such as pain scores, frequency of recurrent joint effusion, and discomfort during daily activities (stair use, squatting, sitting on the floor). When the response is poor, we decide together with you whether to consider additional injections, revisit rehabilitation design, or switch to orthopedic surgical re-evaluation. We also communicate that individual variability exists and that we cannot give a definitive guarantee of results.
Q. Is there a rough timeline for returning to sports?
It varies greatly depending on background factors, the current intra-articular condition, and the treatment received. Pain calming down after a stem cell conditioned media knee injection and patellar stability sufficient to withstand direction changes and landings are separate evaluation axes; the latter is mainly assessed through strength and movement testing during rehabilitation. Because rushing return raises re-dislocation risk, please always decide the stages together with your physician.
──────────────
Supervising Physician: Shin Moriwaki, MD
Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine
ECFMG Certificate (US Medical License Qualification)
──────────────
📍AVAN TOKYO Ginza Regenerative Medicine
AVAN TOKYO 銀座 再生医療
English / 中文 / Tiếng Việt supported
Inquiries welcome via DM / LINE / Website / Phone.